IRCT20180603039959N3CompletedPhase 2
The effect of supplementation with Selenium on serum inflammatory factors of beta thalassemia major patients.
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 42
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Having thalassemia major or intermedia
- •Healthy liver and kidney function
Exclusion Criteria
- •Severe heart, liver or kidney failure
- •History of chemotherapy
- •Diabetic patients
- •Patients with fever and acute and chronic inflammatory infections
- •Taking any selenium supplement for at least two months before the study
Investigators
Similar Trials
Not yet recruiting
Phase 3
The effect of supplementation with organic selenium on sperm parameters, serum levels of androgens, sexual function, and quality of sexual life in infertile meMale infertilityIRCT20131009014957N11Tabriz University of Medical Sciences80
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Completed
Phase 4
The effect of selenium supplementation in moderate-to-severe thyroid eye disease patients : a randomized-placebo controlled trialModerate-to-severe thyroid eye disease patientsInactiveTCTR20170827002The Ratchadapiseksompotch Fund, Faculty of Medicine46
Completed
Phase 2
The effect of selenium on nephropathy complications of diabetic patientsnon-insulin-dependent diabetes mellitus with renal complicationsE11.2diabetic nephropathy.IRCT2015060622562N1Vice chancellor for research, Kashan University of Medical Sciences60
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60